Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 109

1.

CD81 and hepatitis C virus (HCV) infection.

Fénéant L, Levy S, Cocquerel L.

Viruses. 2014 Feb 6;6(2):535-72. doi: 10.3390/v6020535. Review.

2.

CD81-receptor associations--impact for hepatitis C virus entry and antiviral therapies.

Zona L, Tawar RG, Zeisel MB, Xiao F, Schuster C, Lupberger J, Baumert TF.

Viruses. 2014 Feb 18;6(2):875-92. doi: 10.3390/v6020875. Review.

3.

EWI-2wint promotes CD81 clustering that abrogates Hepatitis C Virus entry.

Potel J, Rassam P, Montpellier C, Kaestner L, Werkmeister E, Tews BA, Couturier C, Popescu CI, Baumert TF, Rubinstein E, Dubuisson J, Milhiet PE, Cocquerel L.

Cell Microbiol. 2013 Jul;15(7):1234-52. doi: 10.1111/cmi.12112. Epub 2013 Feb 16.

PMID:
23351194
4.

Mice Expressing Minimally Humanized CD81 and Occludin Genes Support Hepatitis C Virus Uptake In Vivo.

Ding Q, von Schaewen M, Hrebikova G, Heller B, Sandmann L, Plaas M, Ploss A.

J Virol. 2017 Jan 31;91(4). pii: e01799-16. doi: 10.1128/JVI.01799-16. Print 2017 Feb 15.

5.

Significance of palmitoylation of CD81 on its association with tetraspanin-enriched microdomains and mediating hepatitis C virus cell entry.

Zhu YZ, Luo Y, Cao MM, Liu Y, Liu XQ, Wang W, Wu DG, Guan M, Xu QQ, Ren H, Zhao P, Qi ZT.

Virology. 2012 Aug 1;429(2):112-23. doi: 10.1016/j.virol.2012.03.002. Epub 2012 May 4.

6.

Hepatitis C virus induces CD81 and claudin-1 endocytosis.

Farquhar MJ, Hu K, Harris HJ, Davis C, Brimacombe CL, Fletcher SJ, Baumert TF, Rappoport JZ, Balfe P, McKeating JA.

J Virol. 2012 Apr;86(8):4305-16. doi: 10.1128/JVI.06996-11. Epub 2012 Feb 8.

7.

A view of the E2-CD81 interface at the binding site of a neutralizing antibody against hepatitis C virus.

Harman C, Zhong L, Ma L, Liu P, Deng L, Zhao Z, Yan H, Struble E, Virata-Theimer ML, Zhang P.

J Virol. 2015 Jan;89(1):492-501. doi: 10.1128/JVI.01661-14. Epub 2014 Oct 22.

8.

Identification of transferrin receptor 1 as a hepatitis C virus entry factor.

Martin DN, Uprichard SL.

Proc Natl Acad Sci U S A. 2013 Jun 25;110(26):10777-82. doi: 10.1073/pnas.1301764110. Epub 2013 Jun 10.

9.

Impact of single nucleotide polymorphisms in the essential HCV entry factor CD81 on HCV infectivity and neutralization.

Deest M, Westhaus S, Steinmann E, Manns MP, von Hahn T, Ciesek S.

Antiviral Res. 2014 Jan;101:37-44. doi: 10.1016/j.antiviral.2013.10.018. Epub 2013 Nov 7.

PMID:
24211330
10.

CD81 and claudin 1 coreceptor association: role in hepatitis C virus entry.

Harris HJ, Farquhar MJ, Mee CJ, Davis C, Reynolds GM, Jennings A, Hu K, Yuan F, Deng H, Hubscher SG, Han JH, Balfe P, McKeating JA.

J Virol. 2008 May;82(10):5007-20. doi: 10.1128/JVI.02286-07. Epub 2008 Mar 12.

11.

Hepatitis C virus infection propagates through interactions between Syndecan-1 and CD81 and impacts the hepatocyte glycocalyx.

Grigorov B, Reungoat E, Gentil Dit Maurin A, Varbanov M, Blaising J, Michelet M, Manuel R, Parent R, Bartosch B, Zoulim F, Ruggiero F, Pécheur EI.

Cell Microbiol. 2017 May;19(5). doi: 10.1111/cmi.12711. Epub 2016 Dec 23.

PMID:
27930836
12.

Two conserved histidines (His490 and His621) on the E2 glycoprotein of hepatitis C virus are critical for CD81-mediated cell entry.

Qin ZL, Ju HP, Gao TT, Wang WB, Ren H, Zhao P, Qi ZT.

J Gen Virol. 2015 Jun;96(Pt 6):1389-99. doi: 10.1099/vir.0.000091. Epub 2015 Feb 20.

PMID:
25701820
13.

CLEC4M-positive and CD81-negative Huh7 cells are not susceptible to JFH-1 HCVcc infection but mediate transinfection.

Ishibashi M, Morita N, Nomura-Kawaguchi C, Shimizu Y, Wakita T, Esumi M.

Arch Virol. 2014 Nov;159(11):2949-55. doi: 10.1007/s00705-014-2150-z. Epub 2014 Jun 26.

PMID:
24965233
14.

Structural basis of ligand interactions of the large extracellular domain of tetraspanin CD81.

Rajesh S, Sridhar P, Tews BA, Fénéant L, Cocquerel L, Ward DG, Berditchevski F, Overduin M.

J Virol. 2012 Sep;86(18):9606-16. doi: 10.1128/JVI.00559-12. Epub 2012 Jun 27.

15.

Hepatoma polarization limits CD81 and hepatitis C virus dynamics.

Harris HJ, Clerte C, Farquhar MJ, Goodall M, Hu K, Rassam P, Dosset P, Wilson GK, Balfe P, Ijzendoorn SC, Milhiet PE, McKeating JA.

Cell Microbiol. 2013 Mar;15(3):430-45. doi: 10.1111/cmi.12047. Epub 2012 Nov 20.

16.

Different requirements for scavenger receptor class B type I in hepatitis C virus cell-free versus cell-to-cell transmission.

Catanese MT, Loureiro J, Jones CT, Dorner M, von Hahn T, Rice CM.

J Virol. 2013 Aug;87(15):8282-93. doi: 10.1128/JVI.01102-13. Epub 2013 May 22.

17.

A role for CD81 and hepatitis C virus in hepatoma mobility.

Brimacombe CL, Wilson GK, Hübscher SG, McKeating JA, Farquhar MJ.

Viruses. 2014 Mar 24;6(3):1454-72. doi: 10.3390/v6031454.

18.

How hepatitis C virus invades hepatocytes: the mystery of viral entry.

Zhu YZ, Qian XJ, Zhao P, Qi ZT.

World J Gastroenterol. 2014 Apr 7;20(13):3457-67. doi: 10.3748/wjg.v20.i13.3457. Review.

19.

Hepatitis C virus entry and the tetraspanin CD81.

Farquhar MJ, Harris HJ, McKeating JA.

Biochem Soc Trans. 2011 Apr;39(2):532-6. doi: 10.1042/BST0390532. Review.

PMID:
21428934
20.

Role of hypervariable region 1 for the interplay of hepatitis C virus with entry factors and lipoproteins.

Bankwitz D, Vieyres G, Hueging K, Bitzegeio J, Doepke M, Chhatwal P, Haid S, Catanese MT, Zeisel MB, Nicosia A, Baumert TF, Kaderali L, Pietschmann T.

J Virol. 2014 Nov;88(21):12644-55. doi: 10.1128/JVI.01145-14. Epub 2014 Aug 20.

Supplemental Content

Support Center